Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON.

Authors :: Daenen, S
van der Holt, B
Dekker, A W
Willemze, R
Rijneveld, A W
Biemond, B J
Muus, P
van de Loosdrecht, A A
Schouten, H C
van Marwijk Kooy, M
Breems, D A
Demuynck, H
Maertens, J
Wijermans, P W
Wittebol, S
de Klerk, E W
Cornelissen, J J
Source :: Leukemia (08876924); Jul2012, Vol. 26 Issue 7, p1726-1729, 4p, 2 Charts, 1 Graph
Publication Year :: 2012
Abstract: The article presents a study which examines the feasibility and effectiveness of intensive chemotherapy in acute lymphoblastic leukemia (ALL) patients over the age of 40. It notes that the study was participated by 60 patients with ALL who were treated with intensive chemotherapeutic regimen. It concludes that the regimen of intensive chemotherapy is feasible and demonstrated efficacy in patients with ALL up to 70 years of age.

Subjects :: LYMPHOBLASTIC leukemia treatment
DRUG therapy
THERAPEUTICS
DRUG efficacy
FEASIBILITY studies

Full Text Access

Tools